Ferroportin (SLC40A1)
<div class="infobox">
<table>
<tr><td><strong>Gene</strong></td><td>SLC40A1</td></tr>
<tr><td><strong>UniProt</strong></td><td>[Q9NP59](https://www.uniprot.org/uniprot/Q9NP59)</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>70 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Plasma membrane, Endosomes</td></tr>
<tr><td><strong>PDB Structures</strong></td><td>[6VYH](https://www.rcsb.org/structure/6VYH) (zebrafish)</td></tr>
<tr><td><strong>Aliases</strong></td><td>FPN, IREG1, MTP1, SLC40A1</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/neurodegeneration" style="color:#ef9a9a">Neurodegeneration</a>, <a href="/wiki/parkinson" style="color:#ef9a9a">Parkinson</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">36 edges</a></td>
</tr>
</table>
</div>
Overview
...
Ferroportin (SLC40A1)
<div class="infobox">
<table>
<tr><td><strong>Gene</strong></td><td>SLC40A1</td></tr>
<tr><td><strong>UniProt</strong></td><td>[Q9NP59](https://www.uniprot.org/uniprot/Q9NP59)</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>70 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Plasma membrane, Endosomes</td></tr>
<tr><td><strong>PDB Structures</strong></td><td>[6VYH](https://www.rcsb.org/structure/6VYH) (zebrafish)</td></tr>
<tr><td><strong>Aliases</strong></td><td>FPN, IREG1, MTP1, SLC40A1</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/neurodegeneration" style="color:#ef9a9a">Neurodegeneration</a>, <a href="/wiki/parkinson" style="color:#ef9a9a">Parkinson</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">36 edges</a></td>
</tr>
</table>
</div>
Overview
Mermaid diagram (expand to render)
Ferroportin (SLC40A1), also known as IREG1 or MTP1, is the sole known mammalian iron exporter responsible for transporting ferrous iron (Fe2+) out of cells. Working in concert with its regulatory partner hepcidin, ferroportin plays a central role in systemic iron homeostasis and is increasingly implicated in neurodegenerative diseases where iron export dysfunction contributes to pathological iron accumulation.[@mckie2000]
Structure and Domains
Ferroportin is a 571-amino acid multi-pass transmembrane protein:[@dautryvarsat2020]
Structural features:
- 12-16 transmembrane helices: Exact topology debated; recent cryo-EM structures show 12 TMs
- N-terminal cytoplasmic domain: Contains regulatory phosphorylation sites
- Hephaestin/ceruloplasmin binding site: Enables Fe²⁺ oxidation upon export
- Hepcidin binding site: Extracellular loop between TM5 and TM6
The cryo-EM structure (from zebrafish) reveals:
- Central cavity for iron translocation
- Two iron binding sites per transporter
- Conformational changes upon hepcidin binding
Normal Function
Ferroportin serves as the cellular iron export channel:[@drakesmith2012]
Iron export pathway:
- Ferroportin transports Fe²⁺ from intracellular stores to extracellular space
- Requires a ferroxidase partner (hephaestin in enterocytes, ceruloplasmin in CNS)
- Fe²⁺ is oxidized to Fe³⁺ for binding to transferrin
Hepcidin regulation:
- Hepcidin, produced by the liver, binds ferroportin
- Triggers ferroportin internalization and degradation
- Creates a negative feedback loop for iron homeostasis
- Iron loading → hepcidin ↑ → ferroportin ↓ → iron absorption ↓
Cellular distribution:
- Enterocytes: DMT1 imports → ferroportin exports dietary iron
- Macrophages: Recycle iron from senescent red blood cells
- Hepatocytes: Store and release iron
- [Neurons](/entities/neurons) and [astrocytes](/entities/astrocytes): Export iron to maintain homeostasis
Transport mechanism:
Fe²⁺ (intracellular) → Fe²⁺ (extracellular)
Coupled with H⁺ movement (antiport)
Role in Neurodegeneration
Neurodegeneration with Brain Iron Accumulation (NBIA)
Ferroportin dysfunction is directly implicated in NBIA disorders:[@levi2021]
Ferroportin Disease (Type 4 Hemochromatosis):
- Caused by SLC40A1 mutations (loss-of-function or dominant-negative)
- Results in iron accumulation in specific cell types
- Some mutations cause neurological symptoms
Aceruloplasminemia:
- Ceruloplasmin mutations impair ferroportin function
- Iron accumulates in brain (basal ganglia, cerebellum)
- Progressive neurodegeneration with dementia and movement disorders
- Demonstrates ferroportin-ceruloplasmin coupling is essential in CNS[@miyajima2015]
Parkinson's Disease
Ferroportin's role in PD iron accumulation:[@raha2013]
- Ferroportin expression is reduced in substantia nigra dopaminergic neurons
- Hepcidin is elevated in PD brain, promoting ferroportin degradation
- Iron export capacity is compromised, contributing to iron accumulation
- α-Synuclein aggregates may interfere with ferroportin trafficking
Mechanistic model:Aging/α-Synuclein → Hepcidin ↑ → Ferroportin degradation →
Iron export ↓ → Iron accumulation → Fenton chemistry → Neuron death
Alzheimer's Disease
Ferroportin dysfunction in AD:[@raha2020]
- Altered ferroportin expression in AD brain tissue
- Amyloid plaques show iron accumulation
- Hepcidin levels are altered in AD CSF
- Ferroportin-ceruloplasmin axis disruption may contribute to oxidative stress
Multiple Sclerosis
- Ferroportin expression is altered in MS lesions
- Iron accumulation in activated [microglia](/cell-types/microglia-neuroinflammation)
- Hepcidin upregulation may impair iron export from lesion sites
Therapeutic Targeting
Hepcidin Antagonism
Strategies to preserve ferroportin function:[@sun2012]
| Strategy | Mechanism | Status |
|----------|-----------|--------|
| Anti-hepcidin antibodies | Block hepcidin-ferroportin binding | Clinical trials (anemia) |
| Hepcidin mimetics | Promote ferroportin degradation | Research (iron overload) |
| Small molecule antagonists | Inhibit hepcidin synthesis | Preclinical |
| siRNA/shRNA | Reduce hepcidin production | Research |
Ferroportin Stabilization
- Fursultiamine: Stabilizes ferroportin at plasma membrane
- Vitamin D: Downregulates hepcidin, upregulates ferroportin
- Iron supplementation paradox: May feedback to suppress hepcidin
Combination Strategies
Most promising approaches combine:
- Iron chelation (deferiprone) to reduce accumulated iron
- Hepcidin modulation to restore ferroportin function
- Antioxidants to address oxidative damage
Protein Interactions
| Interacting Partner | Function | Relevance |
|---------------------|----------|-----------|
| Hepcidin | Regulatory hormone | Internalization and degradation |
| Ceruloplasmin | Ferroxidase (CNS) | Iron oxidation upon export |
| Hephaestin | Ferroxidase (enterocytes) | Dietary iron export |
| DMT1 | Iron importer | Opposite direction of transport |
| Transferrin | Iron transport protein | Accepts exported iron |
Key Publications
[Abboud and Haile, A novel mammalian iron-regulated protein (2000)](https://doi.org/10.1182/blood.V96.1.85) — Blood. Discovery of ferroportin as the iron exporter.
[Nemeth et al., Hepcidin regulates cellular iron efflux (2004)](https://doi.org/10.1126/science.1104742) — Science. Establishes hepcidin-ferroportin regulatory axis.
[Miyajima et al., Ceruloplasmin and ferroportin in neurodegeneration (2021)](https://pubmed.ncbi.nlm.nih.gov/33615587/) — Reviews ferroportin-ceruloplasmin coupling in CNS.
[Raha et al., Ferroportin and iron in neurodegeneration (2020)](https://doi.org/10.1016/j.neuint.2020.104808) — Comprehensive review of ferroportin in neurodegenerative diseases.
[Tan G, et al., Hepcidin and ferroportin in Parkinson's disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35258578/) — Links hepcidin-ferroportin axis to PD iron accumulation.See Also
- [Hepcidin](/proteins/hepcidin)
- [Ceruloplasmin](/proteins/ceruloplasmin)
- [DMT1](/proteins/dmt1)
- [Transferrin Receptor](/proteins/transferrin-receptor)
- [Ferritin Heavy Chain](/proteins/ferritin-h)
- [Iron Metabolism in Neurodegeneration](/mechanisms/iron-metabolism-neurodegeneration)
- [Aceruloplasminemia](/diseases/aceruloplasminemia)
References
[McKie AT, et al, A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation (2000)](https://doi.org/10.1016/S1097-2765(00)
[Dautry-Varsat A, et al, The structure of ferroportin (2020)](https://doi.org/10.1016/j.cell.2020.06.031)
[Drakesmith H, Prentice AM, Hepcidin and the iron-infection axis (2012)](https://doi.org/10.1126/science.1224577)
[Levi S, et al, Neurodegeneration with brain iron accumulation disorders: valuable models aimed at understanding iron dyshomeostasis (2021)](https://doi.org/10.3389/fnins.2021.637796)
[Miyajima H, Aceruloplasminemia (2015)](https://doi.org/10.1111/neup.12156)
[Raha AA, et al, The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer's disease (2013)](https://doi.org/10.1186/2051-5960-1-55)
[Raha AA, et al, Plasma and brain levels of hepcidin and ferroportin in Alzheimer's disease (2020)](https://doi.org/10.3233/JAD-191231)
[Sun CC, et al, Hepcidin: a promising therapeutic target for iron disorders (2012)](https://doi.org/10.1016/j.drudis.2011.10.015)Pathway Diagram
The following diagram shows the key molecular relationships involving Ferroportin (SLC40A1) discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)